Patient safety in intensive care medicine
Improving the outcome of critically ill patients remains an ideal that every practicing Intensivist strives to achieve. Every year there are many hundreds of research papers published that help us to better understand the physiology and pathophysiology of our patients and also how our treatment strategies interact and eventually alter a patient's course. Many of these papers focus on discrete parts of the therapeutic regimes that we are able to deliver; however, few have had a significant impact on overall outcome measures that are relevant to patients themselves. One area of medicine that is often overlooked, but can impact significantly on relevant patient outcomes, is the process of care. The way we practice, the culture we work in, the climate that our professional demeanor creates can all dramatically impact on outcome measures. Unfortunately, these topics are often not easy to explain, difficult to study and do not attract research funding that stimulates scientific minds to address the problem. This paper describes how the European Society of Intensive Care Medicine (ESICM) aims to raise patient safety to the top of the scientific agenda with the hope of ultimately increasing the quality of care delivered to our patients and improving their outcomes.
The Institute of Medicine (IOM) published in 1999 their seminal report entitled 'To err is human: building a safer health system' [1] . This paper described quality as the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge. Safety was defined as the absence of clinical error, either by commission (unintentionally doing the wrong thing) or omission (unintentionally not doing the right thing) [2] , and error as the failure of a planned action to be completed as intended or the use of a wrong plan to achieve an aim. The accumulation of errors results in accidents. The authors delineated just how common failure to provide quality care is, with between 44,000 and 98,000 patients dying each year in the USA as a result of a clinical error. This makes medical error the eighth leading cause of death, more frequent than motor vehicle accidents (43, 458) , breast cancer (42, 458) and AIDS (16, 516) . Despite the awareness of patient safety and quality of care issues increasing in both patient and political arenas, this has not translated through to groundbreaking research studies that have ignited the topic with significant outcome benefits [3, 4] .
To improve the profile of these subjects, the ESICM in 2009 has launched a major initiative that will bring together the representatives of Critical Care Societies from around the world (national and international) with the aim of pledging their efforts and resources towards improving the care of our patients. Together with the societies signing this Declaration of Vienna (Appendix 1) will be senior representatives from the political world, our partners in industry and of course patient representatives themselves. The meeting will assess problems and solutions from around the world irrespective of geographical, political or economic factors. This unique partnership will allow collaborations to be fostered and for partnerships to develop. We hope to be able to use this group to raise the profile of the patient safety agenda and therefore change the way we practice everyday with resultant benefits for all.
From efficacy to effectiveness
Patient safety in intensive care medicine is best evaluated in terms of two dimensions:
• at the individual patient level, by doing good and not doing harm to any individual patient; • at the collective level by doing good and not doing harm to groups of patients, by increasing the safety and the effectiveness of our interventions or in other words, the cost-benefit ratio.
Although at the level of the individual patient there is little difficulty in explaining what is meant by the concept of safe practice, at a collective level this is far more complex. Partly this is because often the concepts are more easily addressed by complex statistical approaches when addressing groups of patients and the fact that they relate to the two pillars of quality, efficacy and effectiveness [5] . This difference between efficacy and effectiveness is very important to understand [6] . Efficacy relates to the capacity of an intervention to produce an effect, for instance in a research trial, effectiveness relates to how well this translates to improved outcomes in real-life pragmatic situations. The standards for the evaluation and reporting of the efficacy of an intervention are now reasonably well established, despite several concerns surrounding methodological pitfalls [7] . These standards have been described both for the individual level situation [8] and also where the evidence is arising from a variety of different sources [9] . When we move from efficacy to effectiveness, the picture is not so clear.
These problems are usually seen when trying to translate research scenarios into everyday clinical practice, or when trying to develop or assess clinical practice recommendations or guidelines. The definitive answer about the risk-benefit balance of any intervention can only be made when the balance between the expected benefits and the expected risks is assessed in the real world, outside of the experimental setting. To move from what is known about the benefits, the risks and the limitations of a certain intervention when applied in a very strict usually non-generalizable cohort of patients to everyday practice is very difficult. This often relates to patient case mix differences, severity of illness differences and the effects of multiple interventions impacting on each other that were not fully assessed in the original trial. If we take clinical practice guidelines, there are many examples of recommendations that have been suggested following single trials that have been subsequently refuted when more data became available [10, 11] . For these reasons, and due to an innate bias between the appraisal of evidence and clinicians own past experience and beliefs [12] , orthodox medicine is often not evidence based [13] , and anecdote is often used as to determine treatment plans [14] .
Why now: the changing demographics of intensive care medicine?
Recent years have witnessed great changes in the topology of the human population. We are now greater in number and older in age. We are sicker and more dependent on prophylactic and preventive therapies. Resources are becoming scarcer and are increasingly becoming more unevenly distributed. Diseases are becoming more global. Technological advancements have allowed, and been the stimulus for, the development of our specialty, intensive care medicine. This specialty cares for and treats patients with acute life-threatening illnesses. The prevention, care and/or cure of these patients are now a global challenge, needing multiple local solutions.
Contrary to previous times, where almost all of the health challenges could be addressed by single interventions, such as vaccines, antibiotics or nutritional supplements, or eventually by small packages of interventions (washing of hands before interventional childbirth, surgery with anesthesia, prophylactic antibiotics before surgery), critical illness is unique in several respects:
• in its dimensions: it is a situation in which every organ and many of the inter-related systems may be affected, either as a primary or secondary phenomena; • in its time-dependence: most of the diagnostic and therapeutic interventions must be performed exceptionally quickly in order to be given a chance to work;
• in its challenges: the acceptability of the practice of intensive care medicine is crucially dependent on the application of the strictest ethical standards. These have to be maintained with the utmost respect for the patient (and their family's) wishes and in accordance with society's values and expectations. These may change with time and certainly change with cultural, religious and geographic demographics; • in its consequences: the increasing prevalence of residual disability post-critical illness, with the consequent burden on the patient, their families and on society as a whole, has an impact for many years after the acute illness.
The current pandemic of critical illness will spare few and will be part of the dying process of millions of human beings in the forthcoming decades, with an increasing number of patients requiring intensive care as part of their therapeutic plans or end of life care. Given the narrow therapeutic margins for a significant number of the interventions belonging to our field, it is probable that a significant number of patients will be injured and will suffer from the unattended consequences of medical practice. An important dimension of this problem, which can either be caused by errors of action or by errors of omission in the process of care delivery, are the educational and training standards of all professionals involved. We have to recognize that the safety of our patient's and also our health-care teams is of the utmost importance. However, despite recent reports on the increasing disparity between the supply and demand of intensive care [15] and on the proven effectiveness of the intervention of intensive care specialists on patient care, both physicians [16, 17] and nurses [18] , this problem remains hidden and unaddressed by planners of health-care systems and those responsible for the planning of medical education. Consequently, we can expect to see an increase in the impact of these phenomena.
Error in intensive care
Two recent studies performed by the Health Services Research and Outcomes Section of the ESICM have helped to bring light to this issue. In the first study, the sentinel events evaluation (SEE) study, Valentin [19] performed an observational, 24-h cross-sectional study of incidents in 205 intensive care units around the world. Thirty-nine serious events were observed for every 100 patient days. The events included medication errors (136 patients), unplanned dislodgement or inappropriate disconnection of lines, catheters and drains (158), equipment failure (112), loss, obstruction or leakage of artificial airway (47) and inappropriate turning-off of alarms (17) . The presence of organ failure, a higher intensity in level of care and time of exposure all related to these events. In 2009, the same group, focusing this time on errors in the administration of parenteral drugs, found 74.5 events per 100 patient days in the SEE 2 study [20] . Interestingly, three quarters of the errors were classified as errors of omission; 1% of the study population experienced permanent harm or died because of a medication error at the administration stage. The odds ratios for the occurrence of at least one parenteral medication error were raised depending on the number of organ failures, the use of any intravenous medication, the number of parenteral administrations, typical interventions in patients in intensive care, a larger intensive care unit, number of patients per nurse and unit occupancy rate. Odds ratios for the occurrence of parenteral medication errors were decreased for the presence of basic monitoring, an existing critical incident reporting system, an established routine of checks at nurses' shift change and an increased ratio of patient turnover to the size of the unit.
Although these above examples all relate to individual patients, a bigger and less reported problem is that of the omission or commission of therapies for populations of patients. In intensive care practice this may relate to the provision of appropriately sized tidal volumes during mechanical ventilation or the timely use of antimicrobial therapy in septic shock [21, 22] . In other clinical situations, it may relate to the patients being discharged post-acute myocardial infarction being prescribed appropriate doses of beta-blocker and statin therapies.
What are the causes of an unsafe ICU and how can we improve the safety culture and environment within our intensive care units?
Defining and assessing safety and quality are only one side of the issue. Often in clinical practice the problem is broader than individual errors, and the whole system is at fault or at the least predisposes to an unsafe environment. When assessing an 'unsafe' ICU, several factors need to be understood, and these fit into two main categories: problems with the organization and structure of the unit and problems with the process of care used.
Perhaps the most obvious factors from the organization or structural point of view relate to the volume of work performed and outcome. This topic remains contentious [23] , although there is good evidence to support centralization and increased volume services in many circumstances [24, 25] (Nathens, 2001 no. 10382). Some authors have described the relationship between patient to nurse ratios and nosocomial infection rates [26] , medication errors [20] , complications and resource use after esophagectomy [18] or more broadly even all the aspects of safety and quality in the hospital [27] . These works lead many authors to conclude that a high-acuity nurse-patient ratio is cost-effective [28] , and that it is crucial to have ICUs adequately staffed [29] .
The process of care relates to issues of teamwork, collaboration and communication. These issues are far more difficult to quantify and are often obscure and forgotten. In intensive care medicine they were perhaps first raised by Pascale le Blanc and Wilmar Schaufeli in the EURICUS studies [30, 31] . They demonstrated these variables to be associated with increasng nosocomial infection rates [32] . Among these aspects, the issue of nurse-physician collaboration in ICUs [33] [34] [35] seems to be crucial. Also, the issue of the transmission of individual information between professionals is today a critical issue [36] , first raised by Donchin in 1995 [37] and later confirmed in the SEE study [19] . Not withstanding these issues, it is important not to forget the well-being of intensive care nurses [38] or the effect of a pharmacist's and/or a nurse's interventions on cost and adverse effects of drug therapy in the ICU [39] [40] [41] .
The need for a multidimensional approach to the minimization of error and the consequent improvement in the clinical and economical effectiveness of an ICU is becoming increasingly clear [42] . When comparing the ''most efficient'' with ''least efficient'' ICUs, Rothen and co-workers demonstrated that only interprofessional rounds, the presence of an emergency department and the geographical region of the hospital were significantly associated with improvement in quality indicators. The adoption of electronic prescribing over handwritten prescription has also been shown to lead to the prescriptions being more readable and complete, with fewer errors. This should result in improved prescribing and a safer environment for the giving of drugs to our patients.
In conclusion, a significant number of dangerous human errors occur in the ICU. Many of these errors can be attributed to problems of communication between the physicians and nurses. Applying human factor engineering concepts to the study of the weak points of a specific ICU may help to reduce the number of errors. Errors should not be considered as an incurable disease, but rather as preventable phenomena, if systems were designed to cope and to minimize the effects and the consequences of these errors [43] .
The challenges for the future
Medicine in the last 200 years has changed dramatically. The nature of health and disease has altered irrevocably, pain has been conquered with anesthesia, and infectious diseases have been fought through a combination of drugs and better public health systems. At the same time our understanding of the pathophysiological process underpinning these changes has improved exponentially. Despite these advancements, our knowledge as to how health-care systems interact and influence the delivery of safe and quality care are poor. The recent ''discovery'' of the epidemic of ''medical error'' as an important cause of morbidity and mortality should not be a surprise. The first step to overcome this preventable epidemic is by the recognition of its existence. For this reason the ESICM is promoting an initiative to bring together all the stakeholders who relate to our specialty in a process aimed at not only raising the profile of patient safety, but to actually improve the outcome of our patients. If the safety of our patients is increased, then the quality of care that we can provide will improve. 4. We strongly believe that increasing patient safety is as crucial to the development of medical practice as the increase in the effectiveness of our interventions. 5. We have today therefore pledged to do whatever is necessary to:
• Increase the knowledge of the causes and reasons for failures to provide a safe environment in the intensive care unit.
• Improve our understanding of the consequences of failure to provide a safe environment for critically ill adult and children and the health-care professionals caring for these patients.
• Develop and promote criteria that can assess safety in the intensive care unit.
• Further our ability to translate the knowledge of safety into improving the quality of care that can be provided to our patients.
By acting together to fulfill these pledges we will improve the safety of intensive care practice and thereby increase the quality of care.
6. Through the design and promotion of safer and even more efficient devices and drugs, we acknowledge that industrial partners have a pivotal role to play in improving patient safety. With the signature of this declaration, manufacturers of biomedical, pharmaceutical and biotechnology companies pledge to:
• Engage in efforts to improve the safety profile of their products.
• Provide resources to facilitate the safe use of their products.
• Release, as soon as they become available, any information related to safety concerns of their products to health-care professionals and regulatory agencies.
7. The agreements reached today will enable us to develop safety criteria that can be used by intensive care units around the world to improve their safe practices and increase the quality of care provided to the benefit of all of our patients.
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Critical care societies who are participating in the initiative 
